Patent
Issued
Title
Score
US05871726
02/16/1999
Tissue specific and tumor growth supperssion by adenovirus comprising prostate specific antigen
100%
US05858673
01/12/1999
Method for detecting prostate cells
100%
US05856112
01/05/1999
Method for selectively inducing biomarker expression in urologic tumor tissue for diagnosis and treatment thereof
100%
US05843144
12/01/1998
Method for treating benign prostatic hyperplasia with thermal therapy
100%
US05800378
09/01/1998
Medical probe device and method
100%
US05807395
09/15/1998
Method and apparatus for RF ablation and hyperthermia
99%
US05788963
08/04/1998
Isolation and/or preservation of dendritic cells for prostate cancer immunotherapy
99%
US05762626
06/09/1998
Transurethral needle ablation device with cystoscope and method for treatment of the prostate
99%
US05749846
05/12/1998
Medical probe device with optical viewing capability
99%
US05735845
04/07/1998
Method of treating the prostate using cryosurgery
99%
US05728815
03/17/1998
Bone and prostate-derived protein factors affecting prostate cancer growth, differentiation, and metastasis
99%
US05861248
01/19/1999
Biomarkers for detection of prostate cancer
98%
US05840501
11/24/1998
Determination of cPSA
98%
US05863536
01/26/1999
Phosphoramidate derivatives
97%
US05861021
01/19/1999
Microwave thermal therapy of cardiac tissue
97%
US05840494
11/24/1998
Method for molecular staging of prostate cancer
97%
US05807309
09/15/1998
Transurethral needle ablation device and method for the treatment of the prostate
97%
US05783681
07/21/1998
Androgen regulation with DNA sequences of rat probasin gene
97%
US05783435
07/21/1998
Prostate cancer drug screenings
97%
US05783182
07/21/1998
Method for identifying metastatic sequences
97%
US05755754
05/26/1998
Device and method for asymmetrical thermal therapy with helical dipole microwave antenna
97%
US05741225
04/21/1998
Method for treating the prostate
97%
US05733316
03/31/1998
Organ separation for thermal therapy
97%
US05861000
01/19/1999
Apparatus for releasing congested prostate fluid
96%
US05854206
12/29/1998
Compounds and methods for treatment and diagnosis of prostate cancer
96%
US05763202
06/09/1998
Methods of detecting prostate carcinoma using a monoclonal antibody to a new antigenic marker in epithelial prostatic cells alone or with a monoclonal antibody to an antigen of LNCaP cells
96%
US05874305
02/23/1999
Androgen-repressed metastatic human prostate cancer cell line
95%
US05843026
12/01/1998
BPH ablation method and apparatus
95%
US05830179
11/03/1998
Urological stent therapy system and method
95%
US05817036
10/06/1998
System and method for treatment of a prostate with a phase fresnel probe
95%
US05785663
07/28/1998
Method and device for mechanical imaging of prostate
95%
US05874539
02/23/1999
Antibodies to nuclear matrix proteins
94%
US05863912
01/26/1999
Method of treatment of hormone-unresponsive metastiatic prostate cancer
94%
US05800486
09/01/1998
Device for transurethral thermal therapy with cooling balloon
94%
US05797950
08/25/1998
Apparatus for releasing congested prostate fluid
94%
US05766888
06/16/1998
Detection of carcinoma metastases by nucleic acid amplification
94%
US05720719
02/24/1998
Ablative catheter with conformable body
94%
US05710007
01/20/1998
Methods for diagnosing prostatic adenocarcinoma
94%
US05866679
02/02/1999
Peptides
93%
US05849011
12/15/1998
Medical device with trigger actuation assembly
93%
US05848986
12/15/1998
Medical probe with electrode guide for transurethral ablation
93%
US05843016
12/01/1998
Electromotive drug administration for treatment of acute urinary outflow obstruction
93%
US05821352
10/13/1998
CDNA collections encoding proteins regulated during programmed cell death, methods of preparation thereof and methods of use thereof
93%
US05817649
10/06/1998
Combination therapy for the prophylaxis and/or treatment of benign prostatic hyperplasia
93%
US05780485
07/14/1998
Use of .alpha.1c specific compounds to treat benign prostatic hyperplasia
93%
US05733315
03/31/1998
Method of manufacture of a transurethral ultrasound applicator for prostate gland thermal therapy
93%
US05849509
12/15/1998
Nuclear matrix proteins
92%
US05814452
09/29/1998
Human prostatic cell lines immortalized by adenovirus 12-simian virus 40 (AD12/SV40) hybrid virus
92%
US05773292
06/30/1998
Antibodies binding portions, and probes recognizing an antigen of prostate epithelial cells but not antigens circulating in the blood
92%
US05716830
02/10/1998
Human prostatic cell lines immortalized by adenovirus 12-simian virus 40 (AD12/SV40) hybrid virus
92%
US05858685
01/12/1999
Prostate specific antigen from benign prostatic hyperplasia and its use in diagnosis
91%
US05851764
12/22/1998
Human prostate tumor inducing gene-1 and uses thereof
91%
US05741648
04/21/1998
Cell analysis method using quantitative fluorescence image analysis
91%
US05856182
01/05/1999
Monoclonal antibodies specific for the PSA-ACT complex
90%
US05824490
10/20/1998
Method for detecting prostate cancer using a reagent which binds prostate cancer-1 protein
90%
US05807978
09/15/1998
Immunogenic peptides of prostate specific antigen
90%
US05795882
08/18/1998
Method of treating prostatic diseases using delayed and/or sustained release vitamin D formulations
90%
US05747264
05/05/1998
Method of diagnosing and monitoring prostate cancer
90%
US05873877
02/23/1999
Medical probe device with transparent distal extremity
89%
US05872150
02/16/1999
Treatment of prostate disease with a nonsteroidal anti-androgenic compound
89%
US05836894
11/17/1998
Apparatus for measuring mechanical parameters of the prostate and for imaging the prostate using such parameters
89%
US05810007
09/22/1998
Ultrasound localization and image fusion for the treatment of prostate cancer
89%
US05780435
07/14/1998
Methods for treating prostate cancer with LHRH-R antagonists
89%
US05843902
12/01/1998
Methods for treating prostate cancer with LHRH antagonists
88%
US05820559
10/13/1998
Computerized boundary estimation in medical images
88%
US05804602
09/08/1998
Methods of cancer treatment using naaladase inhibitors
88%
US05795877
08/18/1998
Inhibitors of NAALADase enzyme activity
88%
US05760045
06/02/1998
Delta-17 and delta-20 olefinic and saturated 17.beta.-substituted-4-aza-5.alpha.-androstan-3-ones as 5.alpha.-reductase inhibitors useful in the prevention and treatment of hyperandrogenic disorders
88%
US05871448
02/16/1999
Stepper apparatus for use in the imaging/treatment of internal organs using an ultrasound probe
87%
US05865788
02/02/1999
Self-contained power sypply and monitoring station for RF tissue ablation
87%
US05799656
09/01/1998
Optical imaging of breast tissues to enable the detection therein of calcification regions suggestive of cancer
87%
US05795883
08/18/1998
Androgens and anabolic agents
87%
US05763490
06/09/1998
Treating prostate cancer with tartrate ions
87%
US05760000
06/02/1998
Inhibition of liver cancer by the use of GnRH and GnRH analogs
87%
US05719032
02/17/1998
Melanoma and prostate cancer specific antibodies for immunodetection and immunotherapy
87%
US05712251
01/27/1998
Treatment method
87%
US05843953
12/01/1998
7-substituted 4-aza cholanic acid derivatives and their use
85%
US05840544
11/24/1998
DNA encoding rantes homolog from prostate
85%
US05830458
11/03/1998
Method for destroying a diseased human cell
85%
US05824488
10/20/1998
Immortalized and malignant human prostatic cell lines
85%
US05804368
09/08/1998
Method for screening for prostate cancer by measuring apolipoprotein D levels in body fluid
85%
US05786362
07/28/1998
Method of treating Hormone independent cancer
85%
US05785641
07/28/1998
Male indwelling urethral catheter sizing system and insertion method
85%
US05753641
05/19/1998
Method of treatment for benign prostatic hyperplasia
85%
US05726018
03/10/1998
Nucleic acid based assays to detect a novel mammalian protein associated with uncontrolled cell division
85%
US05710275
01/20/1998
7.beta.-substituted-4-aza-5.alpha.-androstan-3-ones as 5.alpha.-reductase inhibitors
85%
US05874234
02/23/1999
Assay for a novel mammalian protein associated with uncontrolled cell division
84%
US05865815
02/02/1999
Prostatic obstruction relief catheter
84%
US05858681
01/12/1999
Method for prognosis of prostate cancer
84%
US05856351
01/05/1999
Artemisinin dimer compounds having anticancer activity
84%
US05854202
12/29/1998
Peptide fragments of calreticulin, peptide mimetics thereof, and pharmaceutical compostions comprising same
84%
US05851529
12/22/1998
Recombinant retroviruses
84%
US05837233
11/17/1998
Method for treating tumors
84%
US05830677
11/03/1998
Methods and compositions for the detection of colon cancers
84%
US05792845
08/11/1998
Nucleotides encoding angiostatin protein and method of use
84%
US05786204
07/28/1998
Human prostatic specific reductase
84%
US05756676
05/26/1998
Mammalian protein associated with uncontrolled cell division
84%
US05753477
05/19/1998
Magneto-biolistic methods
84%
US05751059
05/12/1998
Pyroelectric sensor
84%
US05734022
03/31/1998
Antibodies to a novel mammalian protein associated with uncontrolled cell division
84%
US05720286
02/24/1998
Use of A-mode echography for monitoring the position of a patient during ultrasound therapy
84%
USD0393723
04/21/1998
Device for the relief of menstrual discomforts and for the relief of chronic inflammation of prostate gland
84%
US05871481
02/16/1999
Tissue ablation apparatus and method
83%
US05851816
12/22/1998
Cultured high-fidelity three-dimensional human urogenital tract carcinomas and process
83%
US05834442
11/10/1998
Method for inhibiting cancer metastasis by oral administration of soluble modified citrus pectin
83%
US05824686
10/20/1998
Method of treating androgenic alopecia with 5-alpha reductase inhibitors
83%
US05760066
06/02/1998
Compounds and methods for inhibiting hyper-proliferative cell growth
83%
US05760046
06/02/1998
Method of treating androgenic alopecia with 5-.alpha.reductase inhibitors
83%
US05759837
06/02/1998
Chemotherapy for cancer by inhibiting the fatty acid biosynthetic pathway
83%
US05721277
02/24/1998
Compounds and methods for inhibiting hyper-proliferative cell growth
83%
US05719158
02/17/1998
16-substituted-4-aza-androstane 5-alpha-reductase isozyme 1 inhibitors
83%
USD0396287
07/21/1998
Prostate device
83%
US05874077
02/23/1999
Human til cells expressing recombinant TNF prohormone
82%
US05869494
02/09/1999
Uses for barbituric acid analogs
82%
US05869040
02/09/1999
Gene therapy methods and compositions
82%
US05868662
02/09/1999
Method for improving observation conditions in urethra and a cystoscope for carrying out the method
82%
US05860929
01/19/1999
Fractional moving blood volume estimation with power doppler ultrasound
82%
US05856185
01/05/1999
Method for making reflection defective retroviral vectors for infecting human cells
82%
US05843994
12/01/1998
Compositions and methods for treating and preventing pathologies including cancer
82%
US05836951
11/17/1998
Balloon dilation catheter
82%
US05830686
11/03/1998
Tissue-specific enhancer active in prostate
82%
US05824700
10/20/1998
Ortho-quinone derivatives novel synthesis therefor and their use in the inhibition of neoplastic cell growth
82%
US05797849
08/25/1998
Method for carrying out a medical procedure using a three-dimensional tracking and imaging system
82%
US05783387
07/21/1998
Method for identifying and quantifying nucleic acid sequence aberrations
82%
US05776683
07/07/1998
Methods for identifying genes amplified in cancer cells
82%
US05773005
06/30/1998
Purified flavonoid and diterpene 5.alpha.-reductase inhibitors from thuja orientalis for androgen-related diseases
82%
US05769074
06/23/1998
Computer assisted methods for diagnosing diseases
82%
US05767131
06/16/1998
Dihydropyridines and new uses thereof
82%
US05763625
06/09/1998
Synthesis and use of .beta.-lapachone analogs
82%
US05763429
06/09/1998
Method of treating prostatic diseases using active vitamin D analogues
82%
US05759551
06/02/1998
Immunogenic LHRH peptide constructs and synthetic universal immune stimulators for vaccines
82%
US05752971
05/19/1998
Method of treating a flow obstruction
82%
US05747498
05/05/1998
Alkynyl and azido-substituted 4-anilinoquinazolines
82%
US05736517
04/07/1998
Treatment of cancer with peptides
82%
US05720287
02/24/1998
Therapy and imaging probe and therapeutic treatment apparatus utilizing it
82%
US05705334
01/06/1998
Uses for DNA structure-specific recognition protein
82%
US05874222
02/23/1999
M6P/IGF-II receptor tumor suppressor gene
80%
US05872217
02/16/1999
Antibodies which specifically bind a cancer related antigen
80%
US05872114
02/16/1999
Therapeutic methods and delivery systems utilizing sex steroid precursors
80%
US05872107
02/16/1999
Treatment of urogenital cancer with boron neutron capture therapy
80%
US05869606
02/09/1999
Amino acids peptides or derivatives thereof coupled to fats
80%
US05868757
02/09/1999
Method and apparatus for interstitial radiation of the prostate gland
80%
US05864011
01/26/1999
Cancer related antigen
80%
US05863900
01/26/1999
Lhrh antagonists
80%
US05859042
01/12/1999
Five membered heterocyclic compounds
80%
US05859013
01/12/1999
Method for inducing death of neoplastic cells using piperazine derivatives
80%
US05858683
01/12/1999
Methods and compositions for the detection of cervical cancer
80%
US05855921
01/05/1999
Pharmaceutical products for curing tumorous diseases and process for preparing same
80%
US05854229
12/29/1998
Therapeutic methods and delivery systems utilizing sex steroid precursors
80%
US05851993
12/22/1998
Suppression of tumor cell growth by syndecan-1 ectodomain
80%
US05851792
12/22/1998
Aglucone isoflavone enriched vegetable protein whey whey protein material aglucone isoflavone material high genistein content material and high daidzein content material and process for producing the same from a vegetable protein whey
80%
US05846723
12/08/1998
Methods for detecting the RNA component of telomerase
80%
US05843933
12/01/1998
11.beta.-aryl-4-estrenes, process for their production as well as their use as pharmaceutical agents
80%
US05843932
12/01/1998
Therapeutic methods and delivery systems utilizing sex steroid precursors
80%
US05843446
12/01/1998
Immunogenic LHRH peptide constructs and synthetic universal immune stimulators for vaccines
80%
US05840514
11/24/1998
Methods of testing cancer and anticancer drugs
80%
US05837815
11/17/1998
PYK2 related polypeptide products
80%
US05837700
11/17/1998
Therapeutic methods and delivery systems utilizing sex steroid precursors
80%
US05837696
11/17/1998
Method of inhibiting cancer growth
80%
US05837524
11/17/1998
PYK2 related polynucleotide products
80%
US05837251
11/17/1998
Compositions and methods using complexes of heat shock proteins and antigenic molecules for the treatment and prevention of neoplastic diseases
80%
US05834441
11/10/1998
Adeno-associated viral (AAV) liposomes and methods related thereto
80%
US05833860
11/10/1998
Centrifugal adsorptive sample preparation device and method
80%
US05830887
11/03/1998
Health supplements containing phyto-oestrogens, analogues or metabolites thereof
80%
US05830656
11/03/1998
Detecting the expression of the catr1 gene in squamous cell carcinoma
80%
US05829437
11/03/1998
Microwave method and system to detect and locate cancers in heterogenous tissues
80%
US05827682
10/27/1998
Two-step conversion of vegetable protein isoflavone conjugates to aglucones
80%
US05824671
10/20/1998
Therapeutic methods and delivery systems utilizing sex steroid precursors
80%
US05824495
10/20/1998
Cell fixative and preparation, kit and method
80%
US05821223
10/13/1998
Method of stimulating cell growth with a novel broad spectrum human lung fibroblast-derived mitogen
80%
US05817667
10/06/1998
Compounds and methods for the treatment of cancer
80%
US05817481
10/06/1998
Polynucleotides and polypeptides associated with benign prostatic hypertrophy
80%
US05813988
09/29/1998
Time-resolved diffusion tomographic imaging in highly scattering turbid media
80%
US05807849
09/15/1998
Therapeutic methods and delivery systems utilizing sex steroid precursors
80%
US05804396
09/08/1998
Assay for agents active in proliferative disorders
80%
US05800488
09/01/1998
Cryoprobe with warming feature
80%
US05800487
09/01/1998
Cryoprobe
80%
US05798362
08/25/1998
Quinazolinyl-amino derivatives having .alpha.-antagonist activity
80%
US05798347
08/25/1998
Therapeutic methods and delivery systems utilizing sex steroid precursors
80%
US05798097
08/25/1998
Immunogobulin conjugates
80%
US05789427
08/04/1998
Methods and compositions for inhibiting cell proliferative disorders
80%
US05784162
07/21/1998
Spectral bio-imaging methods for biological research, medical diagnostics and therapy
80%
US05783667
07/21/1998
Apoptosis specific Tp30 protein
80%
US05783562
07/21/1998
Luteinizing hormone releasing hormone analogs
80%
US05783403
07/21/1998
Malignant cell type markers of the interior nuclear matrix
80%
US05783087
07/21/1998
Method and apparatus for isolation and purification of immune complexes
80%
US05782848
07/21/1998
Resecting coagulated tissue
80%
US05780496
07/14/1998
Method and compositions for inhibition of adaptor protein/tyrosine kinase interactions
80%
US05780460
07/14/1998
Therapeutic methods and delivery systems utilizing sex steroid precursors
80%
US05776923
07/07/1998
Method of treating or preventing osteoporosis by adminstering dehydropiandrosterone
80%
US05773476
06/30/1998
Methods and compositions for inhibiting cell proliferative disorders
80%
US05773020
06/30/1998
Treatment of erectile dysfunction
80%
US05767139
06/16/1998
Indoles which have steroid 5-.alpha. reductase inhibitory activity
80%
US05766920
06/16/1998
Ex vivo activation of immune cells
80%
US05759535
06/02/1998
Immunotherapeutic strategies for the treatment of cancer
80%
US05744460
04/28/1998
Combination for treatment of proliferative diseases
80%
US05739137
04/14/1998
16-substituted-4-aza-3-oxo-androstane as 5-alpha-reductase isozyme 1 inhibitors
80%
US05733911
03/31/1998
Method for inducing death of neoplastic cells using piperazne derivatives
80%
US05728688
03/17/1998
Therapeutic methods and delivery systems utilizing sex steroid precursors
80%
US05726023
03/10/1998
Immune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the HER-2/neu oncogene is associated
80%